E
EpiCure Therapeutics develops precision genetic therapies aimed at correcting abnormal brain circuits associated with epilepsy. The company utilizes a discovery platform capable of targeting specific brain cell types to create novel therapeutic assets. These assets are being advanced toward clinical trials to provide treatment options for epilepsy patients.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- EpiCure Therapeutics develops precision genetic therapies aimed at correcting abnormal brain circuits associated with epilepsy. The company utilizes a discovery platform capable of targeting specific brain cell types to create therapeutic assets. These advanced therapies are currently being progressed toward clinical trials to address patient needs.